Leerink Partnrs Has Strong Estimate for Bruker Q1 Earnings

Bruker Co. (NASDAQ:BRKR) – Equities research analysts at Leerink Partnrs increased their Q1 2025 EPS estimates for shares of Bruker in a report released on Wednesday, April 16th. Leerink Partnrs analyst P. Souda now forecasts that the medical research company will post earnings of $0.50 per share for the quarter, up from their previous estimate of $0.41. The consensus estimate for Bruker’s current full-year earnings is $2.69 per share. Leerink Partnrs also issued estimates for Bruker’s Q2 2025 earnings at $0.54 EPS, Q3 2025 earnings at $0.65 EPS, Q4 2025 earnings at $0.87 EPS, FY2025 earnings at $2.55 EPS, Q1 2026 earnings at $0.64 EPS, Q2 2026 earnings at $0.63 EPS, Q3 2026 earnings at $0.71 EPS, Q4 2026 earnings at $0.94 EPS, FY2026 earnings at $2.92 EPS and FY2027 earnings at $3.38 EPS.

Several other equities analysts have also commented on BRKR. Guggenheim restated a “buy” rating on shares of Bruker in a report on Monday, February 24th. Wells Fargo & Company decreased their price target on Bruker from $75.00 to $60.00 and set an “overweight” rating on the stock in a research note on Thursday. Citigroup dropped their price objective on Bruker from $75.00 to $50.00 and set a “buy” rating for the company in a research note on Monday, April 7th. Stifel Nicolaus decreased their target price on Bruker from $70.00 to $57.00 and set a “hold” rating on the stock in a research note on Friday, February 14th. Finally, Barclays dropped their target price on Bruker from $60.00 to $50.00 and set an “overweight” rating for the company in a research report on Thursday, April 10th. Six analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $65.00.

Bruker Trading Down 3.9 %

NASDAQ BRKR opened at $36.28 on Friday. Bruker has a 12 month low of $34.10 and a 12 month high of $83.32. The stock has a market capitalization of $5.50 billion, a P/E ratio of 47.74, a PEG ratio of 2.16 and a beta of 1.18. The firm’s 50-day moving average is $44.52 and its two-hundred day moving average is $53.76. The company has a debt-to-equity ratio of 1.15, a current ratio of 1.60 and a quick ratio of 0.77.

Bruker (NASDAQ:BRKR) last released its quarterly earnings results on Thursday, February 13th. The medical research company reported $0.76 earnings per share for the quarter, topping analysts’ consensus estimates of $0.75 by $0.01. Bruker had a return on equity of 21.01% and a net margin of 3.36%.

Institutional Investors Weigh In On Bruker

Hedge funds and other institutional investors have recently modified their holdings of the company. Wealth Enhancement Advisory Services LLC increased its holdings in Bruker by 1.4% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 13,287 shares of the medical research company’s stock valued at $779,000 after buying an additional 177 shares during the last quarter. Quadrant Capital Group LLC increased its holdings in shares of Bruker by 18.2% in the 4th quarter. Quadrant Capital Group LLC now owns 1,273 shares of the medical research company’s stock valued at $75,000 after acquiring an additional 196 shares during the last quarter. Insigneo Advisory Services LLC raised its position in shares of Bruker by 4.7% during the 4th quarter. Insigneo Advisory Services LLC now owns 4,880 shares of the medical research company’s stock worth $286,000 after acquiring an additional 218 shares in the last quarter. Arizona State Retirement System lifted its stake in Bruker by 0.7% during the fourth quarter. Arizona State Retirement System now owns 30,725 shares of the medical research company’s stock worth $1,801,000 after purchasing an additional 222 shares during the last quarter. Finally, CIBC Asset Management Inc boosted its holdings in Bruker by 5.6% in the fourth quarter. CIBC Asset Management Inc now owns 4,233 shares of the medical research company’s stock valued at $248,000 after purchasing an additional 223 shares in the last quarter. 79.52% of the stock is currently owned by institutional investors and hedge funds.

Bruker Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 28th. Shareholders of record on Monday, March 17th were issued a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a yield of 0.55%. The ex-dividend date of this dividend was Monday, March 17th. Bruker’s dividend payout ratio (DPR) is presently 26.32%.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.